Tesamorelin is an analog of GHRH
GLP-1 receptor agonists may be appropriate second-line agents after metformin or even first-line in patients with established cardiovascular disease, chronic kidney disease, or when weight management is a priority
Concurrently, the glucose-lowering strategy has evolved from solely managing hyperglycemia to emphasizing comprehensive, long-term patient benefits
You also gain access to our team of specialists to ask questions and receive ongoing support
Rising diabetes awareness activities and expanding healthcare access are creating opportunities for GLP-1 drug adoption across healthcare providers, pharmaceutical distributors, and telemedicine platforms in major Indian healthcare regions
Research peptides, conversely, are manufactured as pure compounds without additives, intended for scientific investigation and advanced applications